Kidney-Physiopathology
Dr. Simó Schwartz Jr has been appointed as a member of the advisory board of the EU-NCL
Dr. Simó Schwartz Jr, director of the CIBBIM-Nanomedicine of the Vall d’Hebron Institute of Research (VHIR), has been appointed as a member of the advisory board of the Nanomedicine Characterisation Laboratory (EU-NCL). Dr. Schwartz will...
Read moreLa Masia and the AECC promoting a solidarity oil for breast cancer research
The Spanish Association Against Cancer (AECC) and La Masía have presented today the initiative “Aceite de Oliva Solidario” (Solidarity Olive Oil). The goal of the challenge – which starts today and ends on October 19, World Day...
Read morePreclinical Services
Asdent donates more than 120,000 euros to raise funds for the Dent’s disease at Vall d’Hebron
Nacho is a 6-year-old child who was diagnosed when he was 3 with the Dent’s disease; a rare untreatable disease which may result in renal failure. Since the diagnosis, his parents have not stop to reverse this situation getting researchers...
Read moreDr. Simó Schwartz, Scientific, appointed president of the European Society for Nanomedicine (ESNAM)
The objectives of ESNAM are to promote nanomedicine research and facilitate the exchange of knowledge among its members (currently, about 800 members). According to Dr. Simó Schwartz “the dissemination of specialized infrastructure in...
Read moreVHIR brings nanomedicine to the Science Festival
The Vall d’Hebron Research Institute (VHIR) participated once again in the Science Festival, which this year has reached its 10th edition. Dr. Víctor Puntes, head of the group of Design and Pharmacodynamics of Nanoparticles, gave a talk...
Read moreVHIR presented the results of three projects of the TV3’s Marathon 2010
On Wednesday 15 June was held the Symposium on acquired spinal cord and brain injuries, in which have been presented the results of the 30 projects funded in the 2010 edition of the TV3 Marathon. Of these projects, three were carried out at the...
Read moreThe Association for Familial Hypomagnesemia donates once again 15000 € for the research of this disease
For the second year in a row, the Association for Information and Research of Familial Hipomagnesemia (Hipofam) has given 15000 euros to the research group on Renal Physiopathology of Vall d’hebron Research Institute (VHIR) to investigate...
Read moreDr. Schwartz Jr participates in a European nanomedicine project for pancreatic cancer
The Drug Delivery and Targeting group from the CIBBIM-Nanomedicine at VHIR, led by Dr. Simó Schwartz Jr., participates in a new European project, called NoCanTher, which aims to develop treatments with nanomedicine for pancreatic ductal...
Read moreDr. Anna Meseguer receives grant from the American Association for Cancer Research
Dr. Anna Meseguer, head of the Kidney Physiopathology group at the Vall d’Hebron Institute of Research (VHIR), has received the 2016 Research Grant for Immunotherapy in Kidney Cancer of the American Association for Cancer Research, endowed with...
Read moreTaking care of your kidneys, and also of the youngest ones’
Renal disease, those that affect the kidneys are not an issue just for adults. Younger children also suffer. A reality that sometimes is hidden and has led to devote this year’s World Kidney Day to preventing diseases that affect children...
Read more
